Related Experiment Video
Updated: Sep 20, 2026

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
[An eighteen-year study on phenylketonuria]
Wei-min Yu1, Li Xu, Xioa-wen Li
1Department of Genetic and Metabolic Disease, China-Japan Friendship Hospital, China-Japan Friendship Institute of Clinical Medical Science, Beijing 100029, China. yuweim@public.bta.net.cn
Insights
Early diagnosis and treatment of phenylketonuria (PKU) with a low-phenylalanine diet lead to normal development. Tetrahydrobiopterin (BH4) deficiency also shows promising treatment outcomes in PKU patients.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Context:
- Phenylketonuria (PKU) is a genetic disorder.
- BH4 deficiency is another metabolic disorder affecting neurotransmitter synthesis.
- Long-term PKU studies are crucial for understanding disease progression and treatment efficacy.
Purpose:
- To analyze the diagnosis and treatment outcomes of PKU patients.
- To investigate BH4 deficiency in Chinese populations.
- To correlate genotype with intellectual phenotype in PKU.
Summary:
- A study of 603 PKU patients from 1984-2002 showed early treatment leads to normal development, while late treatment improves symptoms.
- 369 patients with hyperphenylalaninemia (HPA) were analyzed for BH4 deficiency, identifying 22 cases with specific mutations and successful treatment outcomes.
- EEG and MRI revealed significant abnormalities in untreated PKU patients, which decreased after dietary intervention.
- Genotype-intellectual phenotype correlation in 29 classical PKU patients indicated a strong association.
Impact:
- Highlights the critical importance of early PKU detection and intervention.
- Provides insights into BH4 deficiency genetics and treatment in China.
- Demonstrates the effectiveness of dietary management and potential therapeutic options for PKU and related disorders.
- Establishes a link between genetic makeup and cognitive outcomes in PKU.
Abstract:
A study on phenylketonuria (PKU) has been carried out in China-Japan Friendship Hospital since 1984. The results revealed that: (1) Totally 603 patients with PKU were diagnosed and treated in the hospital from October 1984 to September 2002. Among which 136 cases were identified by neonatal screening and treated within 3 months. One hundred and ninety-five cases were treated when the children were 3-12 months of age. Another 272 PKU children were diagnosed when they were more than 1 year old. All of these late-treated cases had some signs and symptoms of PKU. Mental retardation was found in 467 cases and various patterns of seizures in 119 cases. After treatment with low-phenylalanine diet, the follow-up for early-treated patients revealed that their physical and mental developments were normal. In late-treated patients, abnormal behaviour was significantly improved and their developmental quotient were elevated. Prenatal gene diagnosis of PKU risk foetus in 22 PKU families was successfully performed. (2) Urinary pterins obtained from 369 HPA patients were measured by HPLC. Twenty two patients with BH4 deficiency have been recognized. Six single base mutations were detected in 18 unrelated northern Chinese BH4 deficiency families, and the mutations at nucleotides 259C-->T and 286G-->A were common mutations. Eighteen BH4 deficient patients were treated with BH4, L-dopa and 5-hydroxytryptophan, and the results were satisfactory. (3) The abnormal rate of EEG was high in untreated patients with PKU, mainly showing epileptiform discharges and partly showing background activity abnormality. The most frequent finding was patchy areas of increased signal intensity in white matter on MRI in the brain of PKU patients, while delayed myelination and brain agenesis were often detected. After dietary treatment, follow-ups with EEG and MRI revealed that the abnormalities were decreased significantly. (4) The relationship between genotype and intellectual phenotype was examined in 29 late-treated patients with classical PKU. It was found that the genotype of 22 patients were compatible with intellectual phenotype and not well matched in 7 cases. The result indicate that the genotype was well matched with intellectual phenotype in classical PKU patients.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

